Ma S - Search Results

1

Docetaxel plus oxaliplatin (DOCOX) as a second-line treatment after failure of fluoropyrimidine and platinum in Chinese patients with advanced gastric cancer.

Zhong H, Zhang Y, Ma S, Ying JE, Yang Y, Yong D, Hang X, Sun Q, Zhong B, Wang D. Zhong H, et al. Among authors: ma s. Anticancer Drugs. 2008 Nov;19(10):1013-8. doi: 10.1097/CAD.0b013e328314b5ab. Anticancer Drugs. 2008. PMID: 18827567

2

Determination of gemcitabine and its metabolite in human plasma using high-pressure liquid chromatography coupled with a diode array detector.

Lin NM, Zeng S, Ma SL, Fan Y, Zhong HJ, Fang L. Lin NM, et al. Among authors: ma sl. Acta Pharmacol Sin. 2004 Dec;25(12):1584-9. Acta Pharmacol Sin. 2004. PMID: 15569401 Free article.

3

[Effect of Supportan on nutritional status and immune function of late-staged gastric cancer patients undergoing chemotherapy].

Zhong HJ, Ying JE, Ma SL. Zhong HJ, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2006 Sep;9(5):405-8. Zhonghua Wei Chang Wai Ke Za Zhi. 2006. PMID: 17043961 Clinical Trial. Chinese.

4

Treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and Gefitinib in a Chinese population.

Ma S, Xu Y, Deng Q, Yu X. Ma S, et al. Lung Cancer. 2009 Aug;65(2):198-203. doi: 10.1016/j.lungcan.2008.10.028. Epub 2008 Dec 16. Lung Cancer. 2009. PMID: 19091441 Clinical Trial.

5

Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxel.

Su D, Smith SM, Preti M, Schwartz P, Rutherford TJ, Menato G, Danese S, Ma S, Yu H, Katsaros D. Su D, et al. Among authors: ma s. Cancer. 2009 Jun 1;115(11):2453-63. doi: 10.1002/cncr.24282. Cancer. 2009. PMID: 19322891 Free article.

6

Endogenous human CaMKII inhibitory protein suppresses tumor growth by inducing cell cycle arrest and apoptosis through down-regulation of the phosphatidylinositide 3-kinase/Akt/HDM2 pathway.

Ma S, Yang Y, Wang C, Hui N, Gu L, Zhong H, Cai Z, Wang Q, Zhang Q, Li N, Cao X. Ma S, et al. J Biol Chem. 2009 Sep 11;284(37):24773-82. doi: 10.1074/jbc.M109.028621. Epub 2009 Jul 8. J Biol Chem. 2009. Retraction in: J Biol Chem. 2021 Jan-Jun;296:100752. doi: 10.1016/j.jbc.2021.100752 PMID: 19586909 Free PMC article. Retracted.

7

Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer.

Fan Y, Lin NM, Ma SL, Luo LH, Fang L, Huang ZY, Yu HF, Wu FQ. Fan Y, et al. Acta Pharmacol Sin. 2010 Jun;31(6):746-52. doi: 10.1038/aps.2010.50. Acta Pharmacol Sin. 2010. PMID: 20523345 Free PMC article. Clinical Trial.

8

[The killing effect of rmhTNF-alpha combined with gemcitabine on human lung adenocarcinoma cells A549.].

Gu C, Zhang Y, Feng J, Ma S, Lu Y, Hong D, Chen J. Gu C, et al. Among authors: ma s. Zhongguo Fei Ai Za Zhi. 2008 Aug 20;11(4):495-9. doi: 10.3779/j.issn.1009-3419.2008.04.004. Zhongguo Fei Ai Za Zhi. 2008. PMID: 20735956 Free article. Chinese.

9

Concomitant chemoradiotherapy using pemetrexed and carboplatin for unresectable stage III non-small cell lung cancer (NSCLC): preliminary results of a phase II study.

Xu Y, Ma S, Ji Y, Sun X, Jiang H, Chen J, Du X, Zheng Y, Qiu G. Xu Y, et al. Among authors: ma s. Lung Cancer. 2011 Jun;72(3):327-32. doi: 10.1016/j.lungcan.2010.09.012. Epub 2010 Nov 5. Lung Cancer. 2011. PMID: 21056507 Clinical Trial.

10

EGFR inhibitors with concurrent thoracic radiation therapy for locally advanced non-small cell lung cancer.

Xu Y, Zhang Y, Ma S. Xu Y, et al. Among authors: ma s. Lung Cancer. 2011 Sep;73(3):249-55. doi: 10.1016/j.lungcan.2011.04.017. Epub 2011 Jun 8. Lung Cancer. 2011. PMID: 21641672 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,491 results

Search Page

Filters